Literature DB >> 3429636

Osteomyelitis caused by Enterobacter taylorae, formerly enteric group 19.

T U Westblom1, M E Coggins.   

Abstract

The first case of osteomyelitis caused by Enterobacter taylorae is presented. The infection occurred as a complication to an open fracture in an otherwise healthy host. Despite antimicrobial therapy, based on in vitro susceptibilities, it was not possible to establish a microbiologic cure.

Entities:  

Mesh：

Year:  1987        PMID： 3429636      PMCID： PMC269512          DOI： 10.1128/jcm.25.12.2432-2433.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  4 in total

Review 1.  Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens.

Authors:  J J Farmer; B R Davis; F W Hickman-Brenner; A McWhorter; G P Huntley-Carter; M A Asbury; C Riddle; H G Wathen-Grady; C Elias; G R Fanning
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

2.  Comparative in vitro susceptibilities of eight Enterobacter species, with special reference to Enterobacter sakazakii.

Authors:  H L Muytjens; J van der Ros-van de Repe
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

3.  Enterobacter asburiae sp. nov., a new species found in clinical specimens, and reassignment of Erwinia dissolvens and Erwinia nimipressuralis to the genus Enterobacter as Enterobacter dissolvens comb. nov. and Enterobacter nimipressuralis comb. nov.

Authors:  D J Brenner; A C McWhorter; A Kai; A G Steigerwalt; J J Farmer
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

4.  Escherichia fergusonii and Enterobacter taylorae, two new species of Enterobacteriaceae isolated from clinical specimens.

Authors:  J J Farmer; G R Fanning; B R Davis; C M O'Hara; C Riddle; F W Hickman-Brenner; M A Asbury; V A Lowery; D J Brenner
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948
  4 in total
  6 in total

Review 1.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

2.  In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin.

Authors:  P Hohl; J Lüthy-Hottenstein; J Zollinger-Iten; M Altwegg
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

3.  Urinary tract infection caused by Enterobacter taylorae.

Authors:  J Reina; F Salva; J Gil; P Alomar
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

Review 4.  Osteomyelitis caused by Enterobacter cancerogenus infection following a traumatic injury: case report and review of the literature.

Authors:  S Garazzino; A Aprato; A Maiello; A Massé; A Biasibetti; F G De Rosa; G Di Perri
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

5.  Enterobacter taylorae, a new opportunistic pathogen: report of four cases.

Authors:  E M Rubinstien; P Klevjer-Anderson; C A Smith; M T Drouin; J E Patterson
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  Pneumonia due to Enterobacter cancerogenus infection.

Authors:  Tülin Demir; Gamze Baran; Tuncay Buyukguclu; Fikriye Milletli Sezgin; Haci Kaymaz
Journal:  Folia Microbiol (Praha)       Date:  2014-06-29       Impact factor: 2.099
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.